| CTRI Number |
CTRI/2019/04/018724 [Registered on: 24/04/2019] Trial Registered Prospectively |
| Last Modified On: |
15/04/2019 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Surgical/Anesthesia |
| Study Design |
Randomized, Parallel Group, Placebo Controlled Trial |
|
Public Title of Study
|
A comparison between zinc sulfate and magnesium sulfate gargle before operation to reduce sore throat after operation |
|
Scientific Title of Study
|
A prospective, randomized, double blind, placebo controlled study between pre operative magnesium sulfate and zinc sulfate gargle for prevention of post operative sore throat following endotracheal intubation. |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Amit Kumar Mondal |
| Designation |
Post graduate trainee |
| Affiliation |
Midnapore Medical College |
| Address |
Department of Anaesthesiology, Midnapore Medical College, Midnapore, Paschim Medinipur
Medinipur WEST BENGAL 721101 India |
| Phone |
|
| Fax |
|
| Email |
mitjuhi.mondal@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Debasish Bhar |
| Designation |
Associate Professor |
| Affiliation |
Midnapore Medical College |
| Address |
Department of Anaesthesiology, Midnapore Medical College, Midnapore, Paschim Medinipur
Medinipur WEST BENGAL 721101 India |
| Phone |
|
| Fax |
|
| Email |
debasish77bhar@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Debasish Bhar |
| Designation |
Associate Professor |
| Affiliation |
Midnapore Medical College |
| Address |
Department of Anaesthesiology, Midnapore Medical College, Midnapore, Paschim Medinipur
Medinipur WEST BENGAL 721101 India |
| Phone |
|
| Fax |
|
| Email |
debasish77bhar@gmail.com |
|
|
Source of Monetary or Material Support
|
| Office of the Principal,
Midnapore Medical College, Govt. of West Bengal, Vidyasagar Road, Paschim Medinipur-721101. |
|
|
Primary Sponsor
|
| Name |
Midnapore Medical College |
| Address |
Midnapore, Paschim Medinipur, West Bengal. Pin-721101 |
| Type of Sponsor |
Government medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Debasish Bhar |
Surgery operation theatre |
Operation Theatre A, Surgical OT Complex, Department of Surgery, Bidhan Block, Midnapore Medical College, Vidyasagar Road, Midnapore, Paschim Medinipur- 721101 Medinipur WEST BENGAL |
8697362730
debasish77bhar@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: K802||Calculus of gallbladder without cholecystitis, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
Gargle with 5% dextrose solution for 30 seconds 15 min before induction of anaesthesia. |
Patients in Group C will receive 20 ml of 5% dextrose solution and will be asked to gargle with this mixture for 30 seconds, 15 min before induction of anesthesia. |
| Intervention |
Gargle with magnesium sulfate solution and zinc sulfate solution for 30 seconds, 15 min before induction of anesthesia. |
Patients in Group A will receive magnesium sulfate solution 20 mg/kg dissolved into 20 ml of 5% dextrose solution and group B will receive zinc sulfate 170 mg dissolved into 20 ml of 5% dextrose solution. Patients will be asked to gargle with this mixture for 30 seconds, 15 min before induction of anesthesia. |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
65.00 Year(s) |
| Gender |
Both |
| Details |
1.Patients giving valid consent
2.Patients undergoing ASA physical status I & II
3.Patients aged between 18 to 65 years of either sex.
4.Patient undergoing elective laparoscopic cholecystctomy under general anaesthesia.
|
|
| ExclusionCriteria |
| Details |
1.Patient’s refusal.
2.Patients with ASA physical status III or more.
3.Patients posted for emergency surgery
4.Patients with history of alcohol or drug abuse.
5.Patients posted for airway related surgery
6.Pregnancy and lactating mother
7.History of recent sore throat, upper respiratory tract infection, common cold
8.Diabetic patients
9.Long term analgesic therapy
10.Patients with hypersensitivity or contraindication to magnesium or zinc
11.Any history of difficult intubation
12.Difficult intubation requiring more than one attempt
13.Patients with neurological ,psychiatric and neuromuscular disorder
14.Patients requiring introduction of Ryle’s tube in peri-operative period
|
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Participant, Investigator and Outcome Assessor Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| To compare the effect of pre operative magnesium sulfate and zinc sulfate gargle on the incidence and severity of post operative sore throat following endotracheal intubation. |
July 2019-June 2020 (12 months) |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
1) Compare heart rate, mean arterial pressure, respiratory rate and oxygen saturation in post operative period among the study groups.
2) To observe the post operative nausea vomiting, pain, sedation and complications if any
|
July 2019-June 2020 (12 months) |
|
|
Target Sample Size
|
Total Sample Size="132" Sample Size from India="132"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 4 |
|
Date of First Enrollment (India)
|
01/07/2019 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
NIL |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
|
Brief Summary
|
Background: The
antiinflammatory and antinociceptive properties of magnesium by inhibiting calcium entry into the cell and N-methyl-D-aspartate-type
(NMDA) glutamate receptors may have a potential role in reducing post
operative sore throat (POST).[1] Several studies also demonstrated
efficacy of magnesium sulfate to reduce incidence and severity of POST.[2,3]
On the other hand, recent studies with topical zinc has shown that
it directly activates receptors that promote epithelial repair and high dose of
oral zinc sulfate decreases the intensity of mucositis, xerostomia and pain in
individuals undergoing chemotherapy or radiotherapy treatments.[4,5] Recently
in 2018, one study has observed significant reduction in the incidence and
severity of POST compared to placebo when zinc sulfate lozenges were used
preoperatively before endotracheal intubation.[6]
Thus, in the present study we
have compared the incidence and severity of post operative sore throat
following endotracheal intubation in patient undergoing laparoscopic
cholecystectomy after pre operative magnesium sulfate and zinc sulfate gargle.
Methodology: After obtaining permission from
Institutional Ethics Committee and written informed consent from patients, 132
adult patients who met inclusion and exclusion criteria will be randomly
allocated to three equal groups (n = 44 in each group) using computer
generated random number list.
Patients in
Group A will receive magnesium sulfate solution 20
mg/kg dissolved into 20 ml of 5% dextrose solution, group B will receive zinc
sulfate 170 mg dissolved into 20 ml of 5% dextrose solution , group C will
receive 20 ml of 5% dextrose.
Patients
will be asked to gurgle slowly with the solution as per allotment of the group
and drug for 30 sec, 15 min before induction of anesthesia. The solution for
gargle will be wrapped in colored nontransparent glasses to ensure blinding.
The anesthesiologist distributing the solution for gargling will be unaware of
the constituent of the drug and allotment of the group and similarly resident
doctors keeping records of different parameters will also be unaware of the
group allotment.
Trachea
will be intubated with a soft seal cuffed sterile polyvinyl chloride ETT with a
standard cuff and an internal diameter of 7 mm for women and 8 mm for men.
Laryngoscopy and tracheal intubation will be performed by an experienced
anesthesiologist after ensuring maximum neuromuscular blocking effect as
assessed by train‑of‑four (TOF) guard. Tracheal tube cuff
will be inflated with sterile water until no air leakage could be heard with a
peak airway pressure at 20 cm H2O. Those patients who required more
than one attempt for passage of the tube will be excluded from the study.
The
patients will be interviewed in a standard fashion by an anesthesiologist
(blinded investigator) who is unaware of the group allocation. On arrival in
the postanesthesia care unit (0 h), and then at half hourly interval for 2
hours POST will be graded on a four point scale
(0–3).[25] After 2 hour POST score will be assessed at 4 hr, 6 hr,
12 hr and 24 hr after extubation. Vital signs, oxygen saturation (SpO2),
visual analogue score and sedation score will be recorded at the same time.
Results
will be analyzed by unpaired Student’s t-test for parametric data and
Mann-Whitney U-test for nonparametric data when two groups will be compared.
One-way ANOVA for parametric data and Kruskal-Wallis test for nonparametric
data will be used while comparing three groups. Fisher’s exact test and Chi-square
test will be used for categorical data as appropriate. P < 0.05 will
be considered statistically significant. All statistical tests will be done by
"STATISTICA" version 9 (StatSoft, Inc. Tulsa, OK, USA).
Expected
outcome: We expect that both of the drugs will reduce the
POST following laryngoscopy and endotracheal intubation but which one is
superior will only be known after the completion of study.
References:
1)
Fawcett WJ, Haxby EJ, Male DA. Magnesium: Physiology and pharmacology. Br J
Anaesth 1999; 83:302–20.
2) Borazan H,
Kececioglu A, Okesli S, Otelcioglu S. Oral Magnesium Lozenge Reduces
Postoperative Sore Throat: A Randomized, Prospective, Placebo-controlled Study. Anesthesiology 2012;117(3):512-518.
3) Teymourian H,
Mohajerani SA, Farahbod A. Magnesium and Ketamine Gargle and Postoperative Sore
Throat. Anesth Pain Med.
2015;5(3):e22367.
4) Arbabi-kalati
F, Arbabi-kalati F, Deghatipour M, Ansari Moghadam A. Evaluation of the
efficacy of zinc sulfate in the prevention of chemotherapy-induced mucositis: a
double-blind randomized clinical trial. Arch Iran Med. 2012 Jul;15(7):413-7.
5) Sharir H,
Zinger A, Nevo A, Sekler I, Hershfinkel M. Zinc released from injured cells is
acting via the Zn2+-sensing receptor, ZnR, to trigger signaling leading to
epithelial repair. J Biol Chem. 2010 Aug 20;285(34):26097-106.
6) Farhang B, Grondin L. The
Effect of Zinc Lozenge on Postoperative Sore Throat: A Prospective Randomized,
Double-Blinded, Placebo-Controlled Study. Anesth Analg 2018; 126(1):78–83.
|